Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Olaf Oberschmidt
Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells as an “Off-The-Shelf Immunotherapy” for Improvement in Cancer Treatment
Frontiers in Immunology
Allergy
Immunology
Related publications
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
Frontiers in Immunology
Allergy
Immunology
Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer
An Introduction to Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Human Cancer
American Journal of Hematology
Hematology
Development of GPC3-specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Chimeric NKG2D Receptor-Bearing T Cells as Immunotherapy for Ovarian Cancer
Cancer Research
Cancer Research
Oncology
394. McSP-Chimeric Antigen Receptor (CAR)-Redirected T Cells Target Multiple Solid Tumors
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Development of Chimeric Antigen Receptor-Redirected T Cell Therapy Targeting L1-Cam in Ovarian Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Chimeric Antigen Receptor T Cells for the Treatment of Lymphoma
Annals of Lymphoma
Chimeric Antigen Receptor (CAR)-redirected T Cells: Is There a Place for Them in Infectious Diseases?
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology